D M Gerlag

Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response

Rogier M. Thurlings, Koen Vos, C A Wijbrandts et al. · Annals of the Rheumatic Diseases · 2007 · 329 citations · Full text

Medicine, Immunology, Internal Medicine +17

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis

Carla A. Wijbrandts, Sander I. van Leuven, Henk Boom et al. · Annals of the Rheumatic Diseases · 2008 · 67 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study

Ruth Klaasen, Tineke Cantaert, Carla A. Wijbrandts et al. · Lara D. Veeken · 2011 · 64 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis

M Inês Pascoal Ramos, Samuel García, Saïda Aarrass et al. · Arthritis Research & Therapy · 2013 · 38 citations · Full text

Medicine, Immunology, Pathobiology +17

The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis

Rogier M. Thurlings, Maria J H Boumans, Janneke Tekstra et al. · Annals of the Rheumatic Diseases · 2010 · 13 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17